Shock: mechanisms and therapy.
D000818:Animals; D002746:Chlorpromazine / Q000627:therapeutic use; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004285:Dogs; D004731:Endotoxins / Q000633:toxicity; D004837:Epinephrine / Q000627:therapeutic use; D004865:Equipment and Supplies, Hospital; D005938:Glucocorticoids / Q000627:therapeutic use; D006439:Hemodynamics; D006801:Humans; D007545:Isoproterenol / Q000627:therapeutic use; D008962:Models, Theoretical; D010643:Phenoxybenzamine / Q000627:therapeutic use; D010646:Phentolamine / Q000627:therapeutic use; D012769:Shock / Q000188:drug therapy* / Q000503:physiopathology*; D012771:Shock, Hemorrhagic / Q000503:physiopathology; D012772:Shock, Septic / Q000503:physiopathology; D013565:Sympatholytics / Q000627:therapeutic use
D004071:Digitalis Glycosides; D004731:Endotoxins; D005938:Glucocorticoids; D013565:Sympatholytics; D010643:Phenoxybenzamine; D007545:Isoproterenol; D002746:Chlorpromazine; D004837:Epinephrine; D010646:Phentolamine